体积 1, 问题 9 (2011)
治疗前景
Chemoprevention of prostate cancer: is there evidence from clinical trials?
Marcelo Langer Wroclawski, Cynthia Kuk, Antonio Finelli, Neil E Fleshner, Alexandre R Zlotta
治疗前景
Therapeutic mesenchymal stem or stromal cells in rheumatic diseases: rationale, clinical data and perspectives
David Guerit, Marie Maumus, Florence Apparailly,Christian Jorgensen,Daniele Noel
评论文章
Advances in the treatment of heparin-induced thrombocytopenia: latest clinical data
Gregor Hron, Andreas Greinacher
评论文章
Oral antiplatelet agents in ischemic heart disease: a review of the latest clinical evidence
Nadia Paarup Dridi, Lene Holmvang, Peter Clemmensen
评论文章
Clinical investigation of desmoteplase in acute ischemic stroke: rationale and progress
Monica Millan, Antoni Davalos
临床试验结果
Design of patent foramen ovale closure trials: the importance of patient-reported outcomes
John D Carroll, Bray Patrick-Lake
会议记录
Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings
Kate Bushby, Edward Connor
临床试验结果
The process of drug development in pediatric oncology: a review of basic principals and a look into the future
Andre Tesainer Brunetto, Rafael Roesler, Ana Lucia Abujamra, Claudio Galvao de Castro, Gilberto chwartsmann, Algemir Lunardi Brunetto